Bu, Jianlong
Pang, Sainan
Kong, Xianglong
Liu, Benkun
Xiao, Qifan
Qu, Changfa
Funding for this research was provided by:
Individualized and precise treatment of lung cancer (Nn10py2017-04, Nn10py2017-04, Nn10py2017-04, Nn10py2017-04, Nn10py2017-04, Nn10py2017-04)
Article History
Received: 10 January 2024
Accepted: 14 June 2024
First Online: 24 June 2024
Declarations
:
: This study was approved by the Institutional Ethics Review Board of Harbin Medical University Cancer Hospital. Informed written consent was obtained from all patients before the study.
: Not applicable.
: The authors declare no competing interests.